Related Experiment Video
Updated: Jun 28, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Evaluating cardiovascular disease risk stratification using multiple-polygenic risk scores and pooled cohort
Yi Seul Park1, Hye-Mi Jang1, Ji Hye Park1
1Division of Genome Science, Department of Precision Medicine, National Institute of Health, Cheongju-si, Republic of Korea.
Combining genetic risk scores with clinical assessments improves cardiovascular disease (CVD) risk stratification. This approach helps identify high-risk individuals for personalized prevention strategies.
Area of Science:
- Genetics
- Cardiology
- Public Health
Background:
- Cardiovascular disease (CVD) is a leading global cause of death.
- Genetic and environmental factors contribute to CVD development.
- Accurate risk prediction is crucial for effective CVD prevention.
Purpose of the Study:
- To evaluate the combined efficacy of multi-polygenic risk scores (wPRSsum) and Pooled Cohort Equations (PCE) for predicting CVD risk in Koreans.
- To assess the added value of genetic information to traditional clinical risk factors.
Main Methods:
- Longitudinal study of 7,612 Korean individuals over 17 years.
- Calculation of weighted sum of polygenic risk scores (wPRSsum) using PRS-CS.
- Recalibration and application of Pooled Cohort Equations (PCE).
- Analysis using Cox proportional hazards models and Kaplan-Meier analysis.
Main Results:
- wPRSsum showed a significant association with incident CVD (HR=1.15).
- The top 20% high-risk genetic group had a 1.50 HR.
- Combined wPRSsum and PCE enhanced CVD risk stratification, especially for high-risk individuals (HR=4.99).
- Predictive model showed slight improvement in males <55 years (C-index=0.640).
Conclusions:
- Integrating multi-polygenic risk scores with clinical tools like PCE enhances CVD risk stratification.
- This combined approach is valuable for identifying high-risk individuals for personalized CVD prevention.
- The findings support tailored strategies for CVD management in diverse populations.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Assessment of blood pressure in brachial artery(two-step method)
Pre-Procedural Guidelines for Assessing Blood Pressure

